openPR Logo
Press release

Biliary Tract Cancers Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | RemeGen, EMD Serono, SMT bio Co., InnoPharmax, Roche, Zymeworks, BMS Eli Lilly, Ipsen, Array BioPharma, Redx Pharma

07-11-2023 05:18 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Biliary Tract Cancers Pipeline Assessment (2023) Covering

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 80+ key pharma and biotech companies are working on 80+ pipeline drugs in the Biliary Tract Cancers therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Biliary Tract Cancers Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Biliary Tract Cancers Therapeutics Market.

The report provides a detailed description of the Biliary Tract Cancers drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Biliary Tract Cancers Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Biliary Tract Cancers Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Biliary Tract Cancers therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Biliary Tract Cancers treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Biliary Tract Cancers drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Biliary Tract Cancers treatment market.

The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Learn More about the Clinical and Commercial Development Activities in the Biliary Tract Cancers Therapeutics Domain:
https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Biliary Tract Cancers Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates

Route of Administration
Biliary Tract Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intravenous
• Subcutaneous
• Oral
• Intramuscular

Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal antibody
• Small molecule
• Peptide

Request for Sample PDF to Understand More About the Biliary Tract Cancers Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Biliary Tract Cancers Therapeutics Analysis
There are approx. 80+ key companies developing therapies for Biliary Tract Cancer. Currently, SMT bio Co., Ltd is leading the therapeutics market with its Biliary Tract Cancer drug candidates in the most advanced stage of clinical development.

Biliary Tract Cancers Companies in the Therapeutics Market Include:
• Yantai Rongchang Pharmaceutical
• RemeGen
• EMD Serono
• SMT bio Co., Ltd.
• CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
• InnoPharmax Inc.
• Lee's Pharmaceutical Limited
• Hoffmann-La Roche
• Shanghai Miracogen Inc.
• Zymeworks Inc.
• Bristol-Myers Squibb
• Eli Lilly and Company
• Ipsen
• Threshold Pharmaceuticals
• Leap Therapeutics
• Hutchison Medipharma Limited
• Array BioPharma
• Redx Pharma Plc
• Compass Therapeutics
• Lee's Pharmaceutical Limited
And Many Others

Emerging and Marketed Biliary Tract Cancers Therapies Covered in the Report Include:
• MRG 002: Miracogen
• Disitamab vedotin: Yantai Rongchang Pharmaceutical
• Envafolimab: Alphamab Oncology
• DKN-01: Leap Therapeutics
And Many More

Get an in-depth Assessment of the Emerging Therapies and Biliary Tract Cancers Companies Actively Working in the Market:
https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Biliary Tract Cancers Current Treatment Patterns
4. Biliary Tract Cancers - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Biliary Tract Cancers Late-Stage Products (Phase-III)
7. Biliary Tract Cancers Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Biliary Tract Cancers Discontinued Products
13. Biliary Tract Cancers Product Profiles
14. Biliary Tract Cancers Companies
15. Biliary Tract Cancers Drugs
16. Dormant and Discontinued Products
17. Biliary Tract Cancers Unmet Needs
18. Biliary Tract Cancers Future Perspectives
19. Biliary Tract Cancers Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight -
• Radiofrequency Ablation Devices Market
https://www.delveinsight.com/report-store/radiofrequency-ablation-devices-market

• Smart Inhalers Market
https://www.delveinsight.com/report-store/smart-inhalers-market

• Persistent Depressive Disorder Market
https://www.delveinsight.com/report-store/persistent-depressive-disorder-market

• Dysthymia Market
https://www.delveinsight.com/report-store/dysthymia-market

• Nasopharyngeal Carcinoma Market
https://www.delveinsight.com/report-store/nasopharyngeal-carcinoma-market

• Spinal Fusion Devices Market
https://www.delveinsight.com/report-store/spinal-fusion-devices-market

• Stereotactic Surgery Devices Market
https://www.delveinsight.com/report-store/stereotactic-surgery-devices-market

• Structural Heart Devices Global Market
https://www.delveinsight.com/report-store/structural-heart-devices-market-market

• Intracardiac Echocardiography Devices Market
https://www.delveinsight.com/report-store/intracardiac-echocardiography-devices-market

• Cardiac Monitoring System Market
https://www.delveinsight.com/report-store/cardiac-monitoring-system-market

• Desmoplastic Small Round Cell Tumors (dsrcts) Market
https://www.delveinsight.com/report-store/desmoplastic-small-round-cell-tumors-market

• Artificial Cornea and Corneal Implant Market
https://www.delveinsight.com/report-store/artificial-cornea-and-corneal-implant-market

• Deep Brain Stimulation Devices Market
https://www.delveinsight.com/report-store/deep-brain-stimulation-devices-market

• Obesity Market
https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market

• Messenger RNA (mRNA)-based Vaccines and Therapeutics Market
https://www.delveinsight.com/report-store/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market

• Narcolepsy Market
https://www.delveinsight.com/report-store/narcolepsy-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biliary Tract Cancers Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | RemeGen, EMD Serono, SMT bio Co., InnoPharmax, Roche, Zymeworks, BMS Eli Lilly, Ipsen, Array BioPharma, Redx Pharma here

News-ID: 3124591 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Biliary

Global Metal Pancreatic Biliary Stent Market Size by Application, Type, and Geog …
According to Market Research Intellect, the global Metal Pancreatic Biliary Stent market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The metal pancreatic biliary stent market is witnessing consistent growth due to the rising prevalence of
Major Market Share Shift in Biliary Catheters Industry: Advancements In Biliary …
What Is the Forecasted Market Size and Growth Rate for the Biliary Catheters Market? The market size for biliary catheters has experienced robust growth in recent years. There is an expected growth from $3.42 billion in 2024 to $3.75 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 9.7%. Factors like increased occurrences of biliary tract ailments, the popularity of minimally invasive procedures, a growing aging population, more
Primary Biliary Cholangitis Treatment Market
Primary Biliary Cholangitis Treatment Market Global Primary Biliary Cholangitis Treatment Market Expected to Reach US$ YY Million by 2030, Growing at a CAGR of YY%: Market Insights and Dynamics The Global Primary Biliary Cholangitis Treatment Market, which reached US$ YY billion in 2022, is anticipated to achieve US$ YY million by 2030, exhibiting a robust CAGR of YY% during the forecast period from 2024 to 2031. Primary Biliary Cholangitis (PBC), formerly known as
Biliary Stents Market - Unleashing Flow: Empowering Biliary Health with Innovati …
Newark, New Castle, USA - new report, titled Biliary Stents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Biliary Stents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Biliary Stents market. The report offers an overview of the market, which
High Prevalence of Biliary Diseases Across the Globe is Driving the Biliary Sten …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.
Rise in Surgical Procedures of Biliary Diseases is Expected to Boost the Biliary …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.